Pilot study of continuous co-infusion of morphine and naloxone in children with sickle cell pain crisis

American Journal of Hematology

Volumn 83, Issue 9, 2008, Pages 728-731

  Koch, Josh ^a   Manworren, Renee ^b   Clark, Lynn ^c   Quinn, Charles T ^a,d   Buchanan, George R ^a,d   Rogers, Zora R ^a,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^c CHILDREN S MEDICAL CENTER   (United States)

^d Southwestern Comprehensive Sickle Cell Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; HYDROXYZINE; MORPHINE; NALOXONE; ONDANSETRON; PROMETHAZINE;

ADOLESCENT; ADULT; ANALGESIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; FACES PAIN SCALE; FEMALE; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; MALE; NAUSEA; PAIN; PILOT STUDY; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; SOMNOLENCE; VISUAL ANALOG SCALE; VOMITING;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERALGESIA; INFUSIONS, INTRAVENOUS; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NAUSEA; PAIN; PAIN MEASUREMENT; PILOT PROJECTS; PRURITUS; VOMITING;

EID: 51449093023     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21213     Document Type: Article

References (27)

1. Cole TB, Sprinkle RH, Smith SJ, Buchanan GR. Intravenous narcotic therapy for children with severe sickle cell pain crisis. Am J Dis Child 1986;140:1255-1259.
2. Silbergleit R, Jancis MO, McNamara RM. Management of sickle cell pain crisis in the emergency department at teaching hospitals. J Emerg Med 1999;17.625-630.
3. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992;77:162-184.
4. Galloway KS, Yaster M. Pain and symptom control in terminally ill children. Pediatr Clin North Am 2000;47:711-746.
5. Gan TJ, Ginsberg B, Glass PS, et al. Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology 1997;87:1075-1081.
6. Joshi GP, Duffy L, Chehade J, et al. Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia. Anesthesiology 1999;90:1007-1011.
7. Maxwell LG, Kaufmann SC, Bitzer S, et al. The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: A double-blind, prospective, randomized, controlled study. Anesth Analg 2005;100:953-958.
8. Choi JH, Lee J, Choi JH, Bishop MJ, Epidural naloxone reduces pruritus and nausea without affecting analgesia by epidural morphine in bupivacaine. Can J Anaesth 2000;47:33-37.
9. Wang JJ, Ho ST, Tzeng JI. Comparison of intravenous nalbuphine infusion versus naloxone in the prevention of epidural morphine-related side effects. Reg Anesth Pain Med 1998;23:479-484.
10. Kendrick WD, Woods AM, Daly MY, et al. Naloxone versus nalbuphine infusion for prophylaxis of epidural morphine-induced pruritus. Anesth Analg 1996;82:641-647.
11. Cepeda MS, Alvarez H, Morales O, Carr DB. Addition of ultralow dose naloxone to postoperative morphine PCA: Unchanged analgesia and opioid requirement but decreased incidence of opioid side effects. Pain 2004;107:41-46.
12. Sartain JB, Barry JJ, Richardson CA, Branagan HC. Effect of combining naloxone and morphine for intravenous patient-controlled analgesia. Anesthesiology 2003;99:148-151.
13. Cepeda MS, Africano JM, Manrique AM, et al. The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period. Pain 2002;96:73-79.
14. Greenwald PW, Provataris J, Coffey J, et al. Low-dose naloxone does not improve morphine-induced nausea, vomiting, or pruritus. Am J Emerg Med 2005;23:35-39.
15. Franck LS, Treadwell M, Jacob E, Vichinsky E. Assessment of sickle cell pain in children and young adults using the adolescent pediatric pain tool. J Pain Symptom Manage 2002;23:114-120.
16. Daly LE, Bourke GJ. Interpretation and Uses of Medical Statistics, 5th ed. Maiden, MA. Oxford: Blackwell Science. 2000.
17. Ueda H, Fukushima N, Kitao T, et al. Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephalin release. Neurosci Lett 1986;65:247-252.
18. Kivity S, Fireman E, Schwarz Y, et al. The effect of naloxone on basophil histamine release from dialyzed patients. Inflamm Res 1997;46:404-406.
19. Crain SM, Shen KF. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain 2000;84:121-131.
20. Crain SM, Shen KF. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia. Brain Res 2001;888:75-82.
21. Crain SM, Shen KF. Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol Sci 1998;19:358-365.
22. Crain SM, Shen KF. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc Natl Acad Sci USA 1995;92:10540-10544.
23. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004;103:4023-4027.
24. Bieri D, Reeve RA, Champion GD, et al. The faces pain scale for the self-assessment of the severity of pain experienced by children: Development, initial validation, and preliminary investigation for ratio scale properties. Pain 1990;41:139-150.
25. Hockenberry MJ, Wilson D, Winkelstein ML. Wong's Essentials of Pediatric Nursing,7th ed. St.Louis.Mosby: Mosby; 2005.
26. Melzack R. The McGill pain questionnaire: Major properties and scoring methods. Pain 1975;1:277-299.
27. Yosipovitch G, Zucker I, Boner G, et al. A questionnaire for the assessment of pruritus: Validation in uremic patients. Acta Derm Venereol 2001;81:108-111.